Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-12-11
2007-12-11
Davis, Zinna N. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S310000, C546S122000, C546S146000
Reexamination Certificate
active
11125647
ABSTRACT:
The present invention is directed to compounds of Formula I:which are modulators of chemokine receptors. The compounds of the invention, and compositions thereof, are useful in the treatment of diseases related to chemokine receptor expression and/or activity.
REFERENCES:
patent: 4353734 (1982-10-01), Seres et al.
patent: 5770573 (1998-06-01), Arrhenius et al.
patent: 6362177 (2002-03-01), Shiota et al.
patent: 6410566 (2002-06-01), Shiota et al.
patent: 6451842 (2002-09-01), Shiota et al.
patent: WO 97/44329 (1997-11-01), None
patent: WO 99/25686 (1999-05-01), None
patent: WO 00/69432 (2000-11-01), None
patent: WO 00/69815 (2000-11-01), None
patent: WO 01/10439 (2001-02-01), None
patent: WO 03/092586 (2003-11-01), None
patent: WO 03/093231 (2003-11-01), None
patent: WO 03/093266 (2003-11-01), None
patent: WO 2004/041161 (2004-05-01), None
patent: WO 2004/041163 (2004-05-01), None
patent: WO 2004/041279 (2004-05-01), None
patent: WO 2004/041777 (2004-05-01), None
patent: WO 2004/042351 (2004-05-01), None
patent: WO 2004/050024 (2004-06-01), None
patent: WO 2005/044264 (2005-05-01), None
patent: WO 2005/044795 (2005-05-01), None
patent: WO 2005/060665 (2005-07-01), None
patent: WO 2005/067502 (2005-07-01), None
patent: WO 2005/070133 (2005-08-01), None
patent: WO 2005/072361 (2005-08-01), None
patent: WO 2005/110409 (2005-11-01), None
Database CASPLUS on STN (Columbus, OH) No. 136:200479, Kitajima et al., “Preparation of Proline Derivatives as Dipeptidyl Peptidase IV Inhibitors and use thereof as Drugs,” (2002).
Database CASPLUS on STN (Columbus, OH) No. 141:295848, Goodfellow et al., “Preparation of bis(3-aminopyrrolidin-1-yl)methanones as melanin-concentrating hormone receptor antagonists for treatment of obesity and other disorders,” (2004).
Greene,Protective Groups in Organic Synthesis, Ch. 7 “Protection for the Amino Group,” pp. 218-219, p. 232, and p. 236 (1982) Wiley-Interscience.
Bundgaard, “Design of prodrugs',” p. 27 and p. 33 (1986).
Anand Rajan
Cao Ganfeng
Feng Hao
Glenn Joseph
Metcalf Brian W.
Boss Brandon S.
Davis Zinna N.
Goddard Christine
Incyte Corporation
LandOfFree
3-(4-heteroarylcyclohexylamino)cyclopentanecarboxamides as... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 3-(4-heteroarylcyclohexylamino)cyclopentanecarboxamides as..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-(4-heteroarylcyclohexylamino)cyclopentanecarboxamides as... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3860226